Signal active
Investment Firm
Overview
Labcorp specializes in providing physicians with laboratory tests. They develop new tests that provide enhanced accuracy and additional clinical information. Their customers include physicians and their patients, hospitals and managed care plans, private employers, military and law enforcement agencies, and pharmaceutical and biotechnology companies.
Highlights
1978
Biotechnology
10001+
44
9
5
Early Stage Venture, Late Stage Venture, Seed
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
LabCorp, established in 1978 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Cloud Computing, Biotechnology, Health Care, Personal Health, Hospital, Health Diagnostics, Electronic Health Record (EHR), Financial Services, Venture Capital, Finance. The organization boasts a portfolio of 44 investments, with an average round size of $28.8M and 5 successful exits. Their recent investments include Flatiron Health, Google Ventures, Andreessen Horowitz, Social Capital, First Round Capital. The highest investment round they participated in was $99.5B. Among their most notable exits are Flatiron Health and Google Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
Investment portfolio
44
17
9
5
Investments
44
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Oct 24, 2023 | HealthEC | Information Technology | null |
Apr 01, 2024 | Xcell Biosciences | Biotechnology | null |
May 06, 2024 | Phenomix Sciences | Biotechnology | 5.5M |
May 07, 2024 | Acclinate | Health Care | 7.0M |
Exits
5
Funding Timeline
44
0
0
Funding Rounds
44
LabCorp has raised 44 rounds. Their latest funding was raised on May 07, 2024 from a Series A - Acclinate round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Oct 24, 2023 | Venture Round - HealthEC | - | 0 | - |
Apr 01, 2024 | Corporate Round - Xcell Biosciences | - | 0 | - |
May 06, 2024 | Series A - Phenomix Sciences | - | 5.5M | - |
May 07, 2024 | Series A - Acclinate | - | 7.0M | - |
Investors
1
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Debt - LabCorp | 850.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.